MeSH term
Frequency | Condition_Probility | Aged | 5 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Fatal Outcome | 2 | 0.0 |
Female | 16 | 0.0 |
Humans | 53 | 0.0 |
Animals | 44 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Abnormalities, Multiple/*genetics | 11 | 3.0 |
*DNA-Binding Proteins | 4 | 0.0 |
Homeodomain Proteins/genetics | 7 | 3.0 |
Mice | 23 | 0.0 |
*Nuclear Proteins | 38 | 2.0 |
Research Support, Non-U.S. Gov't | 48 | 0.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Base Sequence | 8 | 0.0 |
DNA Mutational Analysis | 9 | 0.0 |
Evolution, Molecular | 2 | 0.0 |
Homeodomain Proteins/*genetics | 11 | 2.0 |
Infant | 3 | 0.0 |
Molecular Sequence Data | 16 | 0.0 |
*Mutation | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 34 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Syndrome | 24 | 1.0 |
Transcription Factors/*genetics | 11 | 0.0 |
Disease Models, Animal | 3 | 0.0 |
Gene Expression Regulation, Developmental | 11 | 1.0 |
Linkage (Genetics) | 3 | 0.0 |
Male | 13 | 0.0 |
Mice, Knockout | 7 | 0.0 |
Mice, Transgenic | 3 | 0.0 |
Phenotype | 12 | 0.0 |
Transforming Growth Factor beta/genetics | 4 | 4.0 |
CHO Cells | 4 | 0.0 |
DNA/metabolism | 7 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Hamsters | 5 | 0.0 |
Hela Cells | 3 | 0.0 |
Homeodomain Proteins/*genetics/metabolism | 3 | 3.0 |
*Aryl Hydrocarbon Hydroxylases | 2 | 0.0 |
Glaucoma/*genetics | 3 | 18.0 |
Molecular Biology | 2 | 0.0 |
Transcription Factors/genetics | 6 | 0.0 |
Chromosomes, Human, Pair 4/genetics | 4 | 5.0 |
Chromosomes, Human, Pair 6/genetics | 2 | 1.0 |
Genotype | 7 | 0.0 |
Iris/*abnormalities | 5 | 35.0 |
Mutation | 9 | 0.0 |
Pedigree | 7 | 0.0 |
Embryonic and Fetal Development | 2 | 0.0 |
Gene Dosage | 2 | 0.0 |
*Gene Expression Regulation, Developmental | 6 | 0.0 |
*Genes, Homeobox | 4 | 1.0 |
Homeodomain Proteins/genetics/*metabolism | 4 | 2.0 |
Immunohistochemistry | 2 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Pregnancy | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 3 | 0.0 |
Adolescent | 5 | 0.0 |
Adult | 7 | 0.0 |
Alleles | 6 | 0.0 |
Child | 3 | 0.0 |
Eye Proteins/*genetics | 2 | 1.0 |
Middle Aged | 5 | 0.0 |
Mutation/*genetics | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 4 | 0.0 |
Binding Sites/physiology | 3 | 1.0 |
Cell Line | 6 | 0.0 |
Genes, Reporter | 3 | 0.0 |
Promoter Regions (Genetics)/physiology | 2 | 1.0 |
Transfection | 7 | 0.0 |
Transgenes | 2 | 0.0 |
Amino Acid Sequence | 10 | 0.0 |
Anterior Eye Segment/*abnormalities | 5 | 33.0 |
Blotting, Western | 2 | 0.0 |
COS Cells | 3 | 0.0 |
Gene Frequency | 2 | 0.0 |
Homeodomain Proteins/*genetics/physiology | 2 | 7.0 |
Point Mutation | 4 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Trans-Activation (Genetics) | 5 | 0.0 |
Transcription Factors/*genetics/physiology | 2 | 2.0 |
Body Patterning/*genetics | 2 | 10.0 |
Body Patterning/genetics | 3 | 10.0 |
*Body Patterning | 2 | 5.0 |
Chick Embryo | 3 | 0.0 |
Heart/embryology | 4 | 6.0 |
*Intercellular Signaling Peptides and Proteins | 4 | 0.0 |
Models, Biological | 2 | 0.0 |
Morphogenesis | 2 | 0.0 |
Promoter Regions (Genetics) | 5 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
*Genes, Dominant | 2 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Protein Binding | 5 | 0.0 |
Homeodomain Proteins/chemistry/*genetics/metabolism | 2 | 16.0 |
Transcription Factors/chemistry/*genetics/metabolism | 2 | 4.0 |
Xenopus | 4 | 0.0 |
*Xenopus Proteins | 6 | 1.0 |
Genes, Reporter/genetics | 3 | 1.0 |
Recombinant Fusion Proteins/metabolism | 4 | 0.0 |
Regulatory Sequences, Nucleic Acid/*genetics | 2 | 2.0 |
Point Mutation/genetics | 2 | 0.0 |
Prolactin/genetics | 2 | 11.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Amino Acid Substitution | 4 | 0.0 |
Codon/genetics | 2 | 0.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Dextrocardia/embryology/genetics | 3 | 100.0 |
Embryonic and Fetal Development/*genetics | 4 | 4.0 |
Morphogenesis/*genetics | 3 | 42.0 |
Body Patterning/genetics/physiology | 2 | 50.0 |
Digestive System/embryology | 2 | 28.0 |
Gene Deletion | 2 | 0.0 |
Mesoderm/metabolism | 3 | 3.0 |
Signal Transduction | 3 | 0.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Mutagenesis | 2 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
Body Patterning/*physiology | 3 | 16.0 |
Gene Expression | 3 | 0.0 |
Heart/*embryology | 3 | 5.0 |
Anodontia/genetics | 2 | 33.0 |
Exons/genetics | 3 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
DNA-Binding Proteins/*genetics | 2 | 0.0 |
Eye Abnormalities/*genetics | 5 | 12.0 |
Transcription Factors/*genetics/*metabolism | 2 | 1.0 |
Craniofacial Abnormalities/genetics | 4 | 16.0 |
Eye Abnormalities/genetics | 5 | 18.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Animals, Newborn | 3 | 0.0 |
Fetal Heart/abnormalities | 2 | 100.0 |
Growth Substances/*physiology | 2 | 1.0 |
Heart Defects, Congenital/embryology/genetics | 4 | 66.0 |
Homeodomain Proteins/genetics/physiology | 3 | 15.0 |
Recombinant Fusion Proteins/physiology | 2 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Spleen/abnormalities | 2 | 28.0 |
Transcription Factors/genetics/physiology | 2 | 3.0 |
Transforming Growth Factor beta/deficiency/genetics/physiology | 2 | 100.0 |
Transposition of Great Vessels/embryology/genetics | 2 | 100.0 |
Viscera/abnormalities | 2 | 66.0 |
*Zebrafish Proteins | 3 | 1.0 |
Trans-Activators/genetics | 2 | 0.0 |
Genes, Homeobox/*genetics | 2 | 3.0 |
*Trans-Activators | 3 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Pituitary Gland/embryology | 2 | 66.0 |
Abnormalities, Multiple/genetics | 3 | 3.0 |
Tooth Abnormalities/genetics | 2 | 25.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
Dimerization | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Oligodeoxyribonucleotides/metabolism | 2 | 4.0 |
Cells, Cultured | 5 | 0.0 |
Translocation, Genetic/*genetics | 3 | 1.0 |
Chromosome Mapping | 3 | 0.0 |
Glaucoma/genetics | 4 | 44.0 |
*Point Mutation | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
English Abstract | 2 | 0.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Homeodomain Proteins/*physiology | 2 | 5.0 |
Blotting, Southern | 2 | 0.0 |
Chromosomes, Human, Pair 4/*genetics | 2 | 2.0 |
DNA Primers | 2 | 0.0 |
Atrial Natriuretic Factor/*genetics | 2 | 16.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Rats | 2 | 0.0 |
Prolactin/*genetics | 2 | 6.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
